The Agentic AI Revolution in Biopharma | PharmExec
· Source: pharmexec.com
In short
The biopharmaceutical industry is undergoing a profound transformation driven by agentic artificial intelligence (AI), autonomous systems that perform complex tasks with minimal human intervention. Agentic AI is revolutionizing workflows across the drug discovery, clinical development, regulatory affairs, commercial operations, manufacturing, and pharmacovigilance stages, accelerating innovation and boosting efficiency. This shift promises to deliver therapies faster and more cost-effectively, while also presenting challenges in data governance, system reliability, regulatory compliance, and organizational adaptation.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 37, 2026: JD.com’s Physical AI and Integrated Platforms Fuel Supply Chain Revolution
Tags: agentic AI, biopharma, drug discovery, clinical trials, regulatory affairs, manufacturing